
Low Institute for Therapeutics and NorthStar Partner to Advance Novel Radioligand Therapy for Cancer-Associated Bone Disease
Low Institute for Therapeutics a pioneering non-profit clinical research organization, and NorthStar Medical Radioisotopes, LLC , a leading radiopharmaceutical company today announced a strategic collaboration to accelerate the development, manufacturing,…

